Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
acetazolamide
acquired immunodeficiency syndrome
advances in neurology
adverse drug reaction
agranulocytosis
alpha-fetoprotein
ammonia
amniocentesis
amyotrophic lateral sclerosis
amyotrophic lateral sclerosis, treatment of
anasarca
anticoagulant, complications of
anticonvulsants
anticonvulsants, blood level determination of
anticonvulsants, compliance
anticonvulsants, effectiveness
anticonvulsants, enzyme inducing
anticonvulsants, hypersensitivity syndrome
anticonvulsants, mechanism of action of
anticonvulsants, selection of
anticonvulsants, teratogenicity of
anticonvulsants, untoward effects of
antidepressant
antiviral agents
arrhythmia, cardiac
aspartate aminotransferase
ataxia
behavioral disorder
breast feeding
calcification, intracranial
calcium antagonist
calcium, serum
cannabidiol
carbamazepine
carbamazepine, toxicity
CAT scan, abnormal
catechol-o-methyltransferase inhibitor
CD4 counts
chemotherapy, CNS treatment and complications with
chest x-ray, abnormal
children
chorea
Clinical Pathologic Conference(C.P.C.)
clobazam
coma
complications
confusion
congenital birth defects
congenital malformation
congenital malformation, non CNS
conjunctivitis
cost effectiveness
coumarin
counselling
cysticercosis
cysticercosis, cerebral
deprenyl
diabetes insipidus
diarrhea
dilantin
dilantin, factors influencing metabolism of
dilantin, hypersensitivity to
dilantin, serum level
drowsiness
drug interactions
drug withdrawal
dyspnea
dyspraxia
edema, facial
edema, periorbital
efficacy
electroencephalogram
ELISA
endemic area
enzyme inhibition
enzyme, defect
enzyme, induction
enzyme, serum
eosinophilia
erythroderma
familial
fat redistribution
fatigue
felbamate
felodipine
fever
fluoxetine
fluvoxamine
folic acid
free radical
gabapentin
gender
generic drugs
genetic counselling
glucose tolerance test, abnormal
Guatemala
headache
headache, progressive
hepatic encephalopathy
hepatic failure
hepatitis
hepatosplenomegaly
human immunodeficiency virus type 1
hyperammonemic encephalopathy
hyperbilirubinemia
hyperglycemia
hyperlipidemia
hyperphosphatasia
hypersensitivity reaction
hypertriglyceridemia
hypocalcemia
iatrogenic neurologic disorders
imbalance
incoordination
indinavir
jaundice
lamotrigine
L-dopa
L-dopa, drug interactions with and side effects of
Lennox-Gastaut syndrome
leukemia
leukocytosis
leukopenia
levonorgestrel
liver function enzymes
lymph node biopsy
lymphadenopathy
manic-depressive
mental status, abnormal
methadone
monoamine oxidase inhibitors
mood change
mortality
motor neuron disease
movement disorder
movement disorder, drug induced
movement disorder, extrapyramidal
movement disorder, treatment of
MRI, abnormal
MRI, contrast enhanced
MRI, ring sign
MRI, vessel wall
MRI, vessel wall enhancement
muscle pain
nausea and vomiting
nelfinavir
nerve conduction studies
neuroleptic
neuroleptic malignant syndrome
neuroleptic, atypical
neuropathy
neutropenia
obstetric neurologic injuries
oral contraceptives
ornithine transcarbamylase deficiency
osteomalacia
oxcarbazepine
pain
pain, central
pain, flank
pain, management of chronic
paresthesias
Parkinson disease
Parkinson disease, drug induced
Parkinson disease, treatment of
Parkinsonism syndrome
paroxetine
patient information and support
personality disorder
phantom limb
phenobarbital
polypharmacy
porphyria
practice guidelines
praziquantel
precipitating factors
pregnancy, anticonvulsants during
pregnancy, neurologic complications in
premarin
prenatal diagnosis by amniocentesis
protease inhibitor, HIV-1
pulmonary function tests
pulmonary infiltrates
quality of life
quinidine
rash
renal failure
renal stones
retrovirus
reversible cerebral vasoconstrictive syndromes
review article
rickets
rifampin
riluzole
risk factors
risperidone
ritonavir
safety
saquinavir
seizure
seizure, adult onset
seizure, drop
seizure, drug-induced
seizure, new onset
seizure, pregnancy
seizure, treatment of
seizure, treatment of, monotherapy
seizure, women
selective serotonin reuptake inhibitors
sertraline
serum alanine aminotransferase
serum glutamic oxaloacetic transaminase
sexual dysfunction in neurologic disease
skin, biopsy
skin, lesions in neurologic disorders
sodium valproate
sodium valproate, toxicity
somnolence
sore throat
statin therapy
subarachnoid hemorrhage
subarachnoid hemorrhage, cerebral convexity
sumatriptan
superior cerebellar artery infarction
systemic illness
teratogenesis
teratogenic drugs
thrombocytopenia
tiagabine
tolcapone
topiramate
treatment of neurologic disorder
tremor
trigeminal neuralgia
trigeminal neuralgia, treatment of
triglycerides
ultrasonography
ultrasonography, head, fetus-neonate
urea-cycle enzymopathies
urticaria
vasculopathy
vertigo
vigabatrin
viral infection
viral load
vitamin D
vitamin deficiency
vitamin K
vitamin supplementation
vitamin, multiple
weight gain
workup
zonisamide
Showing articles 750 to 800 of 1866 << Previous Next >>

Predictors of Multiple Seizures in a Cohort of Children Prospectively Followed from the Time of their First Unprovoked Seizure
Ann Neurol 48:140-147, 137, Shinnar,S. et al, 2000

Two New Drugs for Epilepsy
The Medical Letter, 42:33-35, , 2000

Oxcarbazepine: Double-blind, Randomized, Placebo-control, Monotherapy Trial for Partial Seizures
Neurol 52:732-737, Schachter,S.C. et al, 1999

Lamotrigine-Induced Tourettism
Neurol 52:1191-1194, Lombroso,C.T., 1999

Intranasal Sumatriptan for the Acute Treatment of Migraine in Children
Neurol 52:1507-1510, Ueberall,M.A.&Wenzel,D., 1999

Muscle Pain after Exercise
Lancet 353:1062, Nielen,C.&Mazzone,P., 1999

Lorazepam for the Prevention of Recurrent Seizures Related to Alcohol
NEJM 340:915-919, D'Onofrio,G.,et al, 1999

Medical Management of Epilepsy in Adults
Neurol 51:S15-S20, Mattson,R.H., 1999

Risk Factors for Sudden Unexpected Death in epilepsy:A Case-Control Study
Lancet 353:888-893, Nilsson,L.,et al, 1999

Cardiac Asystole and Bradycardia as a Manifestation of Left Temporal Lobe Complex Partial Seizure
Ann Int Med 130:581-583, Locatelli,E.R.,et al, 1999

Topiramate in Clinical Practice:First Year's Postlicensing Experience in a Specialist Epilepsy Clinic
JNNP 66:759-763, Kellett,M.W.,et al, 1999

Lamotrigine Adjunctive Therapy in painful Phenomena in MS:Preliminary Observations
Neurol 53:433, Cianchetti,C.,et al, 1999

Topiramate-Treated Cluster Headache
Neurol 53:234-236, Wheeler,S.D.&Carrazana,E.J., 1999

Seizure Control and Mortality in Epilepsy
Ann Neurol 46:45-50, Sperling,M.R.,et al, 1999

Safety and Efficacy of Vigabatrin and Carbamazepine in Newly Diagnosed epilepsy:A Multicentre Randomised Double-Blind Study
Lancet 354:13-19, Chadwick,D., 1999

Seizure Frequency and the Health-Related Quality of Life of Adults with epilepsy
Neurol 53:162-166, Leidy,N.K.,et al, 1999

Risk of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis During First Weeks of Antiepileptic Therapy:A Case-Control Study
Lancet 353:2190-2194, Rzany,B.,et al, 1999

Recent Advances, Neurology
BMJ 319:362-366, Larner,A.J.&Farmer,S.F., 1999

Phenobarbital Compared with Phenytoin for the Treatment of Neonatal Seizures
NEJM 341:485-489, Painter,M.J.,et al, 1999

Getting Oriented to Patient-Oriented Outcomes
Neurol 53:662-663, Vickrey,B.G., 1999

Patient-Oriented Outcome Assessment After Temporal Lobectomy for Refractory Epilepsy
Neurol 53:687-694, 662, Gilliam,F.,et al, 1999

Reassessment:Vagus Nerve Stimulation for Epilepsy
Neurol 53:666-669, Fisher,R.S.&Handforth,A., 1999

When to Start and Stop Anticonvulsant Therapy in Children
Arch Neurol 56:1073-1077, Greenwood,R.S.&Tennison,M.B., 1999

Vigabatrin, a Gabaergic Antiepileptic Drug, Causes Concentric Visual Field Defects
Neurol 53:922-926, Kalviainen,R.,et al, 1999

Clinical Benefits of Donepezil:Results from a Long-Term Phase III Extension Trial
Neurol 52:A174, Doody,R.S.,et al, 1999

Multisystem Hypersensitivity Reaction to Lamotrigine
Neurol 53:1367, Sarris,B.M.&Wong,J.G., 1999

Multiple Sclerosis, Side Effects of Interferon Beta Therapy and Their Management
Neurol 53:1622-1627, Walther,E.U.&Hohlfeld,R., 1999

Antiepileptic Drug Regimens and Major Congenital Abnormalities in the Offspring
Ann Neurol 46:739-746, Samren,E.B.,et al, 1999

Intractable Seizures in Pregnancy
Lancet 354:1522, Smith,P.E.M.,et al, 1999

Sudden Unexpected Death in epilepsy (SUDEP): A Clinical Perspective and a Search for Risk Factors
JNNP 67:439-444,427, Kloster,R.&Engelskjon,T., 1999

Psychiatric Adverse Events During Vigabatrin Therapy
Neurol 53:1503-1511, Levinson,D.F.&Devinsky,O., 1999

Long-Term Treatment with Vagus Nerve Stimulation in Patients with Refractory Epilepsy
Neurol 53:1731-1735, Morris,G.L.,et al, 1999

Brief Antiepileptic Drug Withdrawal Prolongs Interval To Next Seizure
Neurol 53:1736-1741, Laowattana,S.,et al, 1999

Functional Magnetic Resonance Imaging in Neuropsychiatry
BMJ 319:1551-1554, Longworth,C.,et al, 1999

Visual Field Defects Associated with Vigabatrin Therapy
JNNP 67:716-722, Lawden,M.C.,et al, 1999

Gabapentin-Induced Anorgasmia
Neurol 53:2209, Clark,J.D.&Elliott,J., 1999

Treatment of Absence Status with Intravenous Valproate
Neurol 52:889-890, Alehan,F.K.,et al, 1999

Cognitive Effects of Topiramate,Gabapentin,And Lamotrigine in Healthy Young Adults
Neurol 52:321-327, Martin,R.,et al, 1999

Drug Treatment of Epilepsy
BMJ 318:106-109, Feely,M., 1999

Buccal Midazolam and Rectal Diazepam for Treatment of Prolonged Seizures in Childhood and Adolescence:A Randomised Trial
Lancet 353:623-626,650, Scott,R.C.,et al, 1999

Focal Lesion in the Splenium of the Corpus Callosum in Epileptic Patients:Antiepileptic Drug Toxicity
AJNR 20:125-129,131, Kim,S.S.,et al, 1999

ACTH Versus Vigabatrin Therapy in Infantile Spasms:A Retrospective Study
Neurol 52:1691-1694,1537, Cossette,P.,et al, 1999

Patients with Refractory Seizures
NEJM 340:1565-1570, Devinsky,O, 1999

Open Comparative Long-Term Study of Vigabatrin vs Carbamazepine in Newly Diagnosed Partial Seizures in Children
Arch Neurol 56:605-607, Zamponi,N.&Cardinali,C., 1999

Visual Field Constriction in Children Treated with Vigabatrin
Neurol 52:1713-1714,1537, Vanhatalo,S.&Paakkonen,L., 1999

Practice Advisory:The Use of Felbamate in the Treatment of Patients with Intractable Epilepsy, Report of the quality Standards Subcommittee of the AAN and the American Epilepsy Society
Neurol 52:1540-1545, French,J.,et al, 1999

Vagus Nerve Stimulation for Medication-Resistant Generalized Epilepsy
Neurol 52:1510-1512, Labar,D.,et al, 1999

Left Vagal nerve Stimulation in Children with Medically Refractory epilepsy
J Pediatr 134:563-566, 532, Murphy,J.V.&Pediatric VNS Study Group, 1999

Evaluation of Refractory epilepsy Treated with Vagus Nerve Stimulation for Up to 5 Years
Neurol 52:1265-1267,1117, Ben-Menachem,E.,et al, 1999

Vagal Nerve Stimulation in epileptic Encephalopathies
Pediatrics 103:778-782, 821, Parker,A.P.J.,et al, 1999



Showing articles 750 to 800 of 1866 << Previous Next >>